Panel Gives Bold Prediction about Bioelectronic Medicine ’s Future

Bioelectronic medicine isn’t new and has been around since the first implantation of the pacemaker. However, in recent years there has been sort of an explosion of the space – with devices. A panel at MD&M West discussed the recent transformation of bioelectronic medicine and where the space was going. “Within the last five years bioelectronic medicine has gotten really exciting,” Barry Keenan, vice president of engineering at BioSig Technologies said. “That’s probably why we’re having this session every year. There’s a very rich pipeline.” BioSig is developing the Pure EP system, a surface electrocardiogram, and an intracardiac multichannel device. It is one of several technologies in this new phase of bioelectronic technology. Gulam Emadi, Principal Systems Engineer at SetPoint Medical clearly defined this new phase to the audience. “We’re jumping ahead to more of this digital dose kind of space where we’re delivering things to alter or correct disease states,” Emadi said. “Our company is paving the way in making people aware of it.” Valencia, CA-based SetPoint is developing a bioelectronic device to treat patients with drug-refractory RA. Perhaps one of the most important moments in the recent history of...
Source: MDDI - Category: Medical Devices Authors: Tags: Electronics Implants Source Type: news